Drug Approvals

FDA Approves First Treatment for Congenital Thrombotic Thrombocytopenic Purpura

Blood Disorders

FDA Approves First Treatment for Congenital Thrombotic Thrombocytopenic Purpura

Nov 13, 2023

1 min read

FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro

FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro

Physician’s Briefing Staff

Nov 09, 2023

2 min read

FDA Approves Voquezna for Erosive Esophagitis, GERD

Physician’s Briefing

FDA Approves Voquezna for Erosive Esophagitis, GERD

Nov 07, 2023

2 min read

FDA Approves Zilbrysq for Generalized Myasthenia Gravis

Physician’s Briefing

FDA Approves Zilbrysq for Generalized Myasthenia Gravis

Oct 24, 2023

1 min read

FDA Approves Nivolumab as Adjuvant Treatment for Melanoma

FDA Approves Nivolumab as Adjuvant Treatment for Melanoma

Oct 18, 2023

1 min read

FDA Approves Velsipity for Moderate-to-Severe Ulcerative Colitis in Adults

Digestive System

FDA Approves Velsipity for Moderate-to-Severe Ulcerative Colitis in Adults

Oct 17, 2023

1 min read

FDA Approves Updated Novavax COVID-19 Vaccine

FDA Approves Updated Novavax COVID-19 Vaccine

Physician’s Briefing Staff

Oct 04, 2023

2 min read

Even Five Years Postapproval, Many Drug Studies Remain Nonpublic

Even Five Years Postapproval, Many Drug Studies Remain Nonpublic

Sep 01, 2023

1 min read

First Biosimilar Approved to Treat Multiple Sclerosis

First Biosimilar Approved to Treat Multiple Sclerosis

Aug 25, 2023

2 min read

Read More

www.healthday.com